top of page

Selected Publications

17

Son, B.¹, Park, S.¹, Cho, S., Kim, J. A., Baek, S. H., Yoo, K. H., Han, D., Joo, J., Park, H. H.*, Park, T. H.* (2024) "Improved neural inductivity of size-controlled 3D human embryonic stem cells using magnetic nanoparticles", Biomaterials Research, Accepted (IF 11.3, JCR 상위 5%)

Corresponding author

16

Son, B.¹, Kim, M.¹, Won, H.¹, Jung, A., Kim, J., Koo, Y., Lee, N. K., Baek, S. H., Han, U., Park, C. G., Shin, H., Gwon, B.*, Joo, J.*, Park, H. H.* (2023) "Secured delivery of basic fibroblast growth factor using human serum albumin-based protein nanoparticles for enhanced wound healing and regeneration", Journal of Nanobiotechnology, Accepted (IF 10.2, JCR 상위 10%)

Corresponding author

15

Lee, G.¹, Kim, S. J.¹, Kim, E. M., Kim, E., Lee, S., Lee, E., Park, H. H.*, Shin, H.* (2022) "Free radical-scavenging composite gelatin methacryloyl hydrogels for cell encapsulation", Acta Biomaterialia, 149, 96-110 (IF 10.633, JCR 상위 10%)

Corresponding author

14

Kim, H.¹, Son, B. R.¹, Seo, E. U.¹, Kwon, M., Ahn, J. H., Shin, H., Song, G. Y., Park, E. J., Na, D. H., Cho, S. W., Kim, H. N.*, Park, H. H.*, Lee, W.* (2022) "Cleavage-responsive biofactory T cells suppress infectious diseases-associated hypercytokinemia", Advanced Science, 9, 26 (IF 17.521, JCR 상위 5%)

Corresponding author

13

Kang, M.¹, Lee, S.H.¹, Kwon, M., Byun, J., Kim, D., Kim, C., Koo, S., Kwon, S. P., Moon, S., Jung, M., Hong, J., Go, S., Song, S. Y., Choi, J. H., Hyeon, T., Oh, Y. K., Park, H. H.*, Kim, B. S.* (2021) "Nanocomplex-mediated in vivo programming to chimeric antigen receptor-M1 macrophages for cancer therapy", Advanced Materials, 10, 862495 (IF 32.086, JCR 상위 3%)

Corresponding author

12

Kim, H.¹, Lee, H.¹, Ahn, J. H.¹, An, J., Hong, K. S., Jang, J. G., An, J., Mun, Y. H., Yoo, S. Y., Choi, Y. J., Yun, M. Y., Song, G. Y., Joo, J., Na, D. H.*, Kim, H. N.*, Park, H. H.*, Lee, J. Y.*, Lee, W.* (2021) "Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm", Nano Today, 38, 101149 (IF 18.962, JCR 상위 3%)

Corresponding author

11

Heo, J.¹, Choi, J.¹, Kim, J. Y., Jeong, H., Choi, D., Han, U., Park, J. H., Park, H. H.*, Hong, J.* (2021) "2D graphene oxide particles induce unwanted loss in pluripotency and trigger early differentiation in human pluripotent stem cells", Journal of Hazardous Materials, 414, 125472 (IF 14.224, JCR 상위 3%)

Corresponding author

10

Park, H. H.¹, Kim, H.¹, Lee, H.¹, Seo, E. U.¹, Kim, J. E.¹, Lee, J. H., Mun, Y. H., Yoo, S. Y., An, J., Yun, M. Y., Kang, N. W., Kim, D. D., Na, D. H., Hong, K. S., Jang, J. G., Ahn, J. H., Bae, J. S.*, Song, G. Y.*, Lee, J. Y.*, Kim, H. N.*, Lee, W.* (2021) "PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses", Biomaterials, 273, 120827 (IF 15.304, JCR 상위 3%)

1 First author

9

Lee, Y. Y.¹, Park, H. H.¹, Park, W.¹, Kim, H.¹, Jang, J. G., Hong, K. S., Lee, J. Y., Seo, H. S., Na, D. H., Kim, T. H., Choy, Y. B., Ahn, J. H.*, Lee, W.*, Park, C. G.* (2021) "Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm" Biomaterials, 267, 120389 (IF 15.304, JCR 상위 3%)

 ¹ First author

8

Park, H. H.¹, Park, W.¹, Lee, Y. Y.¹, Kim, H., Seo, H. S., Choi, D. W., Kwon, H. K., Na, D. H., Kim, T. H., Choy, Y. B., Ahn, J. H.*, Lee, W.*, Park, C. G.* (2020) "Bioinspired DNase-I-coated melanin-like nanospheres for modulation of infection-associated NETosis dysregulation", Advanced Science, 7, 23, 2001940 (IF 17.521, JCR 상위 5%)

1 First author

7

Kim, H. N.¹, Park, H. H.¹, Lim, W.¹, Hong, K. S., Ahn, J. H., Na, D. H., Kim, I. S., Jang, J. G.*, Bae, J. S.*, Lee, W.* (2020) "Ferritin nanocage-based methyltransferase SETD6 for COVID-19 therapy", Advanced Functional Materials, 30, 48, 2006110 (IF 19.924, JCR 상위 5%)

 ¹ First author

6

Lee, W.¹, Ahn, J. H.¹, Park, H. H.¹, Kim, H. N.¹, Kim, H., Yoo, Y., Shin, H., Hong, K. S., Jang, J. G., Park, C. G., Choi, E. Y. *, Bae, J. S.*, Seo, Y. K.* (2020) "COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm", Signal Transduction and Targeted Therapy, 5, 1, 1-11 (IF 38.120, JCR 상위 3%)

 ¹ First author

5

Choi, E. Y.¹, Park, H. H.¹, Kim, H.¹, Kim, H., N., Kim, I., Jeon, S., Kim, W.*, Bae, J. S.*, Lee, W.* (2020) "Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for SARS-CoV-2 patients", European Respiratory Journal, 56, 5, 2001531 (IF 33.801, JCR 상위 3%)

 ¹ First author

4

Park, H. H.¹, Kim, H. N.1, Kim, H.1, Yoo, Y., Shin, H., Choi, E. Y. *, Bae, J. S. *, Lee, W.* (2020) "Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia", Science Advances, 6, 31, eabc1564 (IF 14.980, JCR 상위 5%)

1 First author

3

Park, H. H., Triboulet, R., Bentler, M., Guda, S., Du, P., Xu, H., Gregory, R. I., Brendel, C., Williams, D. A.* (2018) "DROSHA knockout leads to enhancement of viral titers for vectors encoding miRNA-adapted shRNAs", Molecular Therapy-Nucleic Acids, 12, 591-599 (IF 10.183, JCR 상위 10%)

First author

2

Han, U.¹, Park, H. H.¹, Kim Y. J. Park, T. H., Park, J. H.*, Hong, J.* (2017) "Efficient encapsulation and sustained release of basic fibroblast growth factor in nanofilm: extension of the feeding cycle of human induced pluripotent stem cell culture", ACS Applied Materials and Interfaces, 9, 30, 25087-25097 (IF 10.383, JCR 상위 10%)

¹ First author

1

Choi, M.¹, Park, H. H.¹, Choi, D., Han, U., Park, T. H., Lee, H., Park, J. H., Hong, J.* (2017) "Multilayer nanofilms via inkjet printing for stabilizing growth factor and designing desired cell developments", Advanced Healthcare Materials, 6, 14, 1700216 (IF 11.092, JCR 상위 10%)

 ¹ First author

bottom of page